Article Information
History
- November 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Xuejiao Guo1,
- Lin Li1,2,
- Zhe Yan1,
- Yunze Li1,
- Zhiyou Peng1,
- Yixin Yang1,
- Yanfeng Zhang1,
- Christoph Schmitz3,* and
- Zhiying Feng1
- 1Department of Pain Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; fzy1972{at}zju.edu.cn (Z.F.)
- 2Department of Anesthesiology, Yuyao People Hospital of Zhejiang, Ningbo, China
- 3Extracorporeal Shock Wave Research Unit, Chair of Neuroanatomy, Institute of Anatomy, Faculty of Medicine, LMU Munich, Munich, Germany; christoph_schmitz{at}med.uni-muenchen.de (C.S.)
- ↵* Corresponding author; email: christoph_schmitz{at}med.uni-muenchen.de
Posted November 30, 2020.
Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C+E) or C+E alone: a prospective, randomized trial
